Effect of suboccipital release on fibromyalgia symptoms
Effect of Suboccipital Release on Neck Pain and Quality of Life in Patients With Fibromyalgia Syndrome
This study tests if a special therapy called suboccipital release can help women with fibromyalgia feel better compared to standard physical therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 20 Years to 45 Years |
| Sex | Female |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06879743 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of suboccipital release therapy in alleviating symptoms of fibromyalgia in female patients aged 20 to 45. Participants are randomly divided into two groups: one receiving standard physical therapy and the other undergoing suboccipital release treatment. The study measures outcomes such as cortisol levels, pain intensity, and quality of life using various assessment tools over a six-week treatment period. The goal is to provide preliminary evidence on the impact of this intervention on fibromyalgia symptoms.
Who should consider this trial
Good fit: Ideal candidates are women aged 20-45 diagnosed with fibromyalgia according to the 2016 American College of Rheumatology criteria.
Not a fit: Patients with other autoimmune disorders or those using strong pain medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce pain and improve quality of life for patients with fibromyalgia.
How similar studies have performed: While there is limited research specifically on suboccipital release for fibromyalgia, similar manual therapies have shown promise in managing chronic pain conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * women between 20-45 years old, (ii) diagnoses according to the 2016 American College of Rheumatology criteria for fibromyalgia \[1\] * Symptoms have been present at a similar level for at least three months (iii) Absence of other disorders that causes similar symptoms: systemic lupus erethromatosis (SLE), rheumatoid arthritis (RA) and Lyme disease based on laboratory investigations (erythrocyte sedimentation rate (ESR), Anti anti-cyclic citrullinated peptide (Anti CCP), antinuclear antibody (ANA) and Rheumatoid factor(RF)). * Exclusion Criteria: * any medical, neurological, or psychiatric illness, use of strong opioids or other painkillers except paracetamol and/or ibuprofen, benzodiazepine, illicit drug or alcohol use, recent use of cannabis, pregnancy, breast feeding, and the presence of pain syndromes other than FM. Presence of other autoimmune disorders e.g.: rheumatoid arthritis and systemic lupus erethromatosus
Where this trial is running
Cairo
- Faculty of physical therapy laps at cairo university — Cairo, Egypt (Recruiting)
Study contacts
- Study coordinator: Rowida Abdelgleel, Lecturer
- Email: rowidaabdelglel@gmail.com
- Phone: 01152322678
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.